These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
386 related items for PubMed ID: 21554566
1. Melatonin receptor agonists: new options for insomnia and depression treatment. Spadoni G, Bedini A, Rivara S, Mor M. CNS Neurosci Ther; 2011 Dec; 17(6):733-41. PubMed ID: 21554566 [Abstract] [Full Text] [Related]
2. Melatonin and melatonergic drugs on sleep: possible mechanisms of action. Srinivasan V, Pandi-Perumal SR, Trahkt I, Spence DW, Poeggeler B, Hardeland R, Cardinali DP. Int J Neurosci; 2009 Dec; 119(6):821-46. PubMed ID: 19326288 [Abstract] [Full Text] [Related]
4. Melatonin receptor agonists: SAR and applications to the treatment of sleep-wake disorders. Rivara S, Mor M, Bedini A, Spadoni G, Tarzia G. Curr Top Med Chem; 2008 Dec; 8(11):954-68. PubMed ID: 18673165 [Abstract] [Full Text] [Related]
6. Drug Insight: the use of melatonergic agonists for the treatment of insomnia-focus on ramelteon. Pandi-Perumal SR, Srinivasan V, Poeggeler B, Hardeland R, Cardinali DP. Nat Clin Pract Neurol; 2007 Apr; 3(4):221-8. PubMed ID: 17410109 [Abstract] [Full Text] [Related]
11. Role of the melatonin system in the control of sleep: therapeutic implications. Pandi-Perumal SR, Srinivasan V, Spence DW, Cardinali DP. CNS Drugs; 2007 Apr; 21(12):995-1018. PubMed ID: 18020480 [Abstract] [Full Text] [Related]
12. Melatonin and the circadian system: Keys for health with a focus on sleep. Pevet P, Challet E, Felder-Schmittbuhl MP. Handb Clin Neurol; 2021 Apr; 179():331-343. PubMed ID: 34225973 [Abstract] [Full Text] [Related]
13. Tasimelteon: a melatonin receptor agonist for non-24-hour sleep-wake disorder. Johnsa JD, Neville MW. Ann Pharmacother; 2014 Dec; 48(12):1636-41. PubMed ID: 25204464 [Abstract] [Full Text] [Related]